Lazard Freres Gestion S.A.S. Pfizer Inc Transaction History

Lazard Freres Gestion S.A.S.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $6,418 - $7,502	200 Added 2.64%	7,773 $255,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $9,030 - $10,447	-250 Reduced 3.2%	7,573 $276,000
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $61,960 - $80,663	1,573 Added 25.17%	7,823 $269,000
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $71,058 - $92,759	-1,702 Reduced 21.4%	6,250 $320,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $79,194 - $93,899	1,702 Added 27.23%	7,952 $414,000
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $224,437 - $254,250	6,250 New	6,250 $206,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lazard Freres Gestion S.A.S., based on Form 13F filings with the SEC.

Stay updated on Lazard Freres Gestion S.A.S. with notifications on news.